NASDAQ: CTNMContineum Therapeutics Inc Stock Ownership - Who owns Contineum Therapeutics?
Insider buying vs selling
Have Contineum Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel S. Lorrain | Chief Scientific Officer | 2024-11-25 | 1,010 | $16.02 | $16.18kSell |
| Daniel S. Lorrain | Chief Scientific Officer | 2024-11-18 | 99 | $17.05 | $1.69kSell |
| Daniel S. Lorrain | Chief Scientific Officer | 2024-11-18 | 6,091 | $16.37 | $99.73kSell |
| Stephen L. Huhn | CMO Sr VP Clinical Dev. | 2024-08-13 | 12,800 | $1.01 | $12.93kBuy |
CTNM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CTNM insiders and whales buy or sell their stock.
CTNM Shareholders
What type of owners hold Contineum Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Johnson Johnson | 7.65% | 1,979,173 | $7.76M | Insider |
| Johnson Johnson | 7.65% | 1,979,173 | $7.76M | Institution |
| Suvretta Capital Management LLC | 6.65% | 1,720,000 | $6.74M | Institution |
| Franklin Resources Inc | 6.09% | 1,576,181 | $6.18M | Institution |
| Perceptive Advisors LLC | 5.57% | 1,441,249 | $5.65M | Institution |
| Versant Venture Management LLC | 3.55% | 918,163 | $3.60M | Institution |
| Fmr LLC | 3.13% | 810,317 | $3.18M | Institution |
| Vanguard Group Inc | 3.11% | 803,428 | $3.15M | Institution |
| Sectoral Asset Management Inc | 3.10% | 800,787 | $3.14M | Institution |
| Hhlr Advisors Ltd | 2.59% | 669,337 | $2.62M | Institution |
CTNM vs Biotech Stocks
Contineum Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.